NASDAQ: HIT
Health In Tech Inc Stock

$0.61-0.01 (-1.61%)
Updated Apr 30, 2025
HIT Price
$0.61
Fair Value Price
$0.36
Market Cap
$26.05M
52 Week Low
$0.51
52 Week High
$7.59
P/E
60.7x
P/B
1.98x
P/S
14.24x
PEG
N/A
Dividend Yield
N/A
Revenue
$19.49M
Earnings
$670.48k
Gross Margin
79.2%
Operating Margin
7.1%
Profit Margin
3.4%
Debt to Equity
0.2
Operating Cash Flow
$2M
Beta
0.63
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HIT Overview

Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HIT's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: App

Industry Rating
B
HIT
Ranked
#18 of 200

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$12.31A
$2.96A
$1.77A
View Top App Stocks

Be the first to know about important HIT news, forecast changes, insider trades & much more!

HIT News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HIT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HIT ($0.61) is overvalued by 68.33% relative to our estimate of its Fair Value price of $0.36 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HIT ($0.61) is not significantly undervalued (68.33%) relative to our estimate of its Fair Value price of $0.36 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HIT was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HIT due diligence checks available for Premium users.

Valuation

HIT fair value

Fair Value of HIT stock based on Discounted Cash Flow (DCF)

Price
$0.61
Fair Value
$0.36
Overvalued by
69.16%
HIT ($0.61) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HIT ($0.61) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HIT was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HIT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
60.7x
Industry
120.68x
Market
29.18x
HIT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HIT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

HIT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.98x
Industry
7.01x
HIT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HIT's financial health

Profit margin

Revenue
$4.9M
Net Income
-$144.2k
Profit Margin
-2.9%
HIT's Earnings (EBIT) of $1.38M... subscribe to Premium to read more.
Interest Coverage Financials
HIT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$15.8M
Liabilities
$2.6M
Debt to equity
0.2
HIT's short-term assets ($10.78M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HIT's short-term assets ($10.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HIT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$531.2k
Investing
-$542.1k
Financing
$7.2M
HIT's operating cash flow ($2.18M)... subscribe to Premium to read more.
Debt Coverage Financials

HIT vs App Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HITB$26.05M-2.10%60.70x1.98x
CJMBC$23.73M+14.10%-6.14x7.48x
NTWK$28.94M+3.33%-33.51x0.85x
CXAID$22.97M+0.87%-0.95x1.47x
AIXIC$30.04M+17.46%-1.26x-1.54x

Health In Tech Stock FAQ

What is Health In Tech's quote symbol?

(NASDAQ: HIT) Health In Tech trades on the NASDAQ under the ticker symbol HIT. Health In Tech stock quotes can also be displayed as NASDAQ: HIT.

If you're new to stock investing, here's how to buy Health In Tech stock.

What is the 52 week high and low for Health In Tech (NASDAQ: HIT)?

(NASDAQ: HIT) Health In Tech's 52-week high was $7.59, and its 52-week low was $0.51. It is currently -92% from its 52-week high and 18.55% from its 52-week low.

How much is Health In Tech's stock price per share?

(NASDAQ: HIT) Health In Tech stock price per share is $0.61 today (as of Apr 30, 2025).

What is Health In Tech's Market Cap?

(NASDAQ: HIT) Health In Tech's market cap is $26.05M, as of May 2, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Health In Tech's market cap is calculated by multiplying HIT's current stock price of $0.61 by HIT's total outstanding shares of 42,914,870.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.